Earnings Scheduled For March 22, 2024

計劃於2024年3月22日公佈的收益

Benzinga · 03/22 17:40

• Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million.

• Agile Therapeutics（納斯達克股票代碼：AGRX）可能公佈季度虧損爲每股0.54美元，收入爲920萬美元。

• 51 Talk Online Education (AMEX:COE) is projected to report earnings for its fourth quarter.

• 51 Talk Online Education（AMEX: COE）預計將公佈其第四季度的收益。

• Star Equity Hldgs (NASDAQ:STRR) is likely to report quarterly loss at $0.08 per share on revenue of $9.15 million.

• Star Equity Hldgs（納斯達克股票代碼：STRR）可能會報告季度虧損爲每股0.08美元，收入爲915萬美元。

• Hyzon Motors (NASDAQ:HYZN) is likely to report earnings for its fourth quarter.

• Hyzon Motors（納斯達克股票代碼：HYZN）可能會公佈其第四季度的收益。

• Humacyte (NASDAQ:HUMA) is estimated to report quarterly loss at $0.24 per share on revenue of $60 thousand.

• 據估計，Humacyte（納斯達克股票代碼：HUMA）將報告季度虧損爲每股0.24美元，收入爲6萬美元。

• AstroNova (NASDAQ:ALOT) is likely to report earnings for its fourth quarter.

• AstroNova（納斯達克股票代碼：ALOT）可能會公佈其第四季度的收益。

• Sunlands Technology (NYSE:STG) is likely to report earnings for its fourth quarter.

• 桑蘭科技（紐約證券交易所代碼：STG）可能會公佈其第四季度的收益。

• Moleculin Biotech (NASDAQ:MBRX) is estimated to report earnings for its fourth quarter.

• 據估計，Moleculin Biotech（納斯達克股票代碼：MBRX）將公佈其第四季度的收益。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閱。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

風險及免責聲明